Dataset Information
RET somatic mutations are underrecognized in Hirschsprung disease.
Ontology highlight
ABSTRACT: Purpose
We aimed to determine the frequency of RET mosaicism in Hirschsprung disease (HSCR), test whether it has been underestimated, and to assess its contribution to HSCR risk.Methods
Targeted exome sequencing (n?=?83) and RET single-gene screening (n?=?69) were performed. Amplicon-based deep sequencing was applied on multiple tissue samples. TA cloning and sequencing were conducted for validation.Results
We identified eight de novo mutations in 152 patients (5.2%), of which six were pathogenic mosaic mutations. Two of these patients were somatic mosaics, with mutations detected in blood, colon, and saliva (mutant allele frequency: 35-44%). In addition, germ-line mosaicism was identified in four clinically unaffected subjects, each with an affected child, in multiple tissues (mutant allele frequency: 1-28%).Conclusion
Somatic mutations of the RET gene are underrecognized in HSCR. Molecular investigation of the parents of patients with seemingly sporadic mutations is essential to determine recurrence risk in these families.
SUBMITTER: Jiang Q
PROVIDER: S-EPMC7814876 | biostudies-literature | 2018 Jul
REPOSITORIES: biostudies-literature
Publications
RET somatic mutations are underrecognized in Hirschsprung disease.
Genetics in medicine : official journal of the American College of Medical Genetics 20171026 7
<h4>Purpose</h4>We aimed to determine the frequency of RET mosaicism in Hirschsprung disease (HSCR), test whether it has been underestimated, and to assess its contribution to HSCR risk.<h4>Methods</h4>Targeted exome sequencing (n = 83) and RET single-gene screening (n = 69) were performed. Amplicon-based deep sequencing was applied on multiple tissue samples. TA cloning and sequencing were conducted for validation.<h4>Results</h4>We identified eight de novo mutations in 152 patients (5.2%), of ...[more]